Metrizamide in pediatric myelography.
Metrizamide, a new water-solution iodinated contrast medium, was evaluated in 63 infants and children, most of whom had lumbosacral or low thoracic lesions. The diagnostic quality was found to be good, and no serious complications or permanent sequelae were encountered. Chief complications were headache, nausea, vomiting and fever. No myoclonic spasms or convulsions were seen. The advantages and disadvantages of metrizamide are discussed.
D000293:Adolescent; D000328:Adult; D001100:Arachnoiditis / Q000000981:diagnostic imaging; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media / Q000009:adverse effects; D003884:Dermoid Cyst / Q000000981:diagnostic imaging; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007405:Intervertebral Disc Displacement / Q000000981:diagnostic imaging; D007463:Iodobenzoates; D008067:Lipoma / Q000000981:diagnostic imaging; D008588:Meningocele / Q000000981:diagnostic imaging; D008793:Metrizamide / Q000009:adverse effects; D009192:Myelography / Q000009:adverse effects; D012447:Sacrum; D013116:Spinal Cord / Q000002:abnormalities; D013120:Spinal Cord Neoplasms / Q000000981:diagnostic imaging; D013168:Spondylolisthesis / Q000000981:diagnostic imaging
D003287:Contrast Media; D007463:Iodobenzoates; D008793:Metrizamide